bioRxiv · 10.1101/2023.10.28.564488
Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein
Abstract
mRNA vaccines and therapeutics are highly effective and can be developed and manufactured with a relatively short lead time. Here we report an all-enzyme platform to generate capped synthetic RNA in a one-step process based on an RNA capping enzyme-T7 RNA polymerase fusion protein. Under standard in vitro transcription reaction conditions, the fusion protein, in conjunction with an RNA cap 2'-O-methyltransferase, can generate synthetic mRNA with up to 95% of Cap-1 incorporation, greatly simplifying mRNA manufacturing workflows.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Chan, S. H., Tirole, L., Kneller, D. W., Kelley, T. M., Dai, N., Robb, G. B.. 2023-10-28. Co-transcriptional capping using an RNA capping enzyme-T7 RNA polymerase fusion protein. https://doi.org/10.1101/2023.10.28.564488
Cite the original work for its findings. Save a collection to share your selection of sources.